Skip to content
10-Q

Quarterly Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001144204-12-028867

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 15, 2012 50M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$32.21K
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$9.05K
Stockholders Equity Q1 2012 · Mar 31, 2012 $28.73K
Current Liabilities Q1 2012 · Mar 31, 2012 $74.98K
Current Liabilities Q1 2012 · Dec 31, 2011 $70.62K
Total Liabilities Q1 2012 · Mar 31, 2012 $74.98K
Total Liabilities Q1 2012 · Dec 31, 2011 $70.62K
Current Assets Q1 2012 · Mar 31, 2012 $103.7K
Current Assets Q1 2012 · Dec 31, 2011 $20K
Total Assets Q1 2012 · Mar 31, 2012 $103.7K
Total Assets Q1 2012 · Dec 31, 2011 $20K
Net Income Q1 2012 · Mar 31, 2012 −$54.27K
Net Income Q1 2012 · Mar 31, 2011 −$6.65K
Operating Income Q1 2012 · Mar 31, 2012 −$60.09K
Operating Income Q1 2012 · Mar 31, 2011 −$6.65K
Revenue Q1 2012 · Mar 31, 2012 $0
Revenue Q1 2012 · Mar 31, 2011 $0
Cash And Equivalents Q1 2012 · Mar 31, 2011 $0
Cash And Equivalents Q1 2012 · Dec 31, 2010 $0